| Name | Title | Contact Details |
|---|
Enpath Medical, Inc. is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Diamond Recovery Centers is run by members in recovery, industry-leading professionals, and world-class clinicians. Our mission statement is ” If we put the clients and their needs first, everything else will fall in place”. Our only goal is to help those struggling with Mental Health and Substance Abuse one client at a time.
The mission of Cascadia Behavioral Healthcare is to create hope and opportunity for low income people with mental illnesses and addictions, blending innovation and determination with competence, inclusion and compassion. The heart of Cascadia is our people those we serve, our co-workers, and our community partners. Together we are focused on efficiency, committed to diversity and grounded in compassion.We are consumers, counselors, accountants, case managers, nurses, administrative support workers, doctors, and the full complement of all the people needed to bring results. For many of us this is not just a job, it`s a calling. Our Vision: We envision a future where everyone with a mental illness or addiction will recover and have a full life in the community. Our Mission: Cascadia provides healing, homes, and hope for people living with mental health and addiction challenges. Cascadia brings health and housing services to those who need them most. With 75 sites in Oregon`s Multnomah and Clackamas Counties, we help create a sense of community We`ve learned that families are an important part of people`s lives and offer services unique to children, families, adults and older adults: •Community- and Clinic-Based Mental Health and Addiction Services •Peer Wellness •Urgent and Emergency Services •Homeless Services •Forensics •Medical •Housing Development
WellPath Select is a Morrisville, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.